Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Arformoterol Tartrate vs Racemic Formoterol in COPD
NCT00685529Phase 2Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Apr 2005
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arformoterol in chronic obstructive pulmonary disease (COPD), sponsored by Sumitomo Pharma America. Started Apr 2005; status: completed.
02
Drugs
arformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00685529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00685529.